Podcast

Share

Program Content

Activities

  • Q&A: CDK4/6i in Early BC
    CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Expert Answers to Clinician Questions
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 05, 2021

    Expires: August 04, 2022

  • Podcast Pearls: CDK4/6i in EBC
    CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Podcast Pearls
    PDF
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 17, 2021

    Expires: August 16, 2022

Faculty

cover img faculity

Javier Cortes, MD, PhD

Head, Breast Cancer Program
IOB Institute of Oncology
Madrid and Barcelona, Spain

cover img faculity

Stephen Raffanti, MD, MPH

Associate Professor of Medicine
Division of Infectious Disease
Vanderbilt University School of Medicine
Chief Medical Officer
Comprehensive Care Center
Nashville, Tennessee

cover img faculity

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Associate Director, Susan F. Smith Center for Women’s Cancers
Senior Physician, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Lilly